Event-Driven Stocks

GW PHARMACEUTICALS PLC

Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕

Signs● 4 good● 4 warningdetails ↓

Financials

SEC XBRL · annual
 FY20FY19FY18FY17FY16
Revenue$120.6M$39.2M$12.7M$4.0M$12.7M
Operating income−$7.2M−$51.3M−$288.8M−$58.5M−$128.7M
Net income−$8.0M−$50.1M−$295.2M−$61.8M−$91.7M
Total assets$939.5M$882.2M$756.1M$442.9M—
Total liabilities$198.4M$156.2M$82.0M$62.1M—
Equity$741.1M$726.0M$415.2M$380.8M$525.7M
EPS (diluted)—$-0.14———
Shares out.371.7M371.1M366.5M——

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2020
Operating margin
−6.0%
Net margin
−6.6%
Return on equity
−1.1%
Return on assets
−0.8%
Return on capital (ROCE)
−0.9%
Liabilities / assets
21.1%
Debt / equity
0.27×
Book value / share
$1.99
Revenue growth (YoY)
207.4%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2020
Altman Z″ (distress)
4.74safe
Accruals / assets
2.1%clean
Beneish M-Score
-1.24elevated
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
53
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 33Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 4 warning● 4 good
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.